1. Home
  2. ABCL
  3. ABCL News

Latest AbCellera Biologics Inc. (ABCL) News on November 28, 2025

AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss
ABCL

Insider Monkey

3 days ago

AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss

AbCellera Biologics Inc. (ABCL): A Bull Case Theory
ABCL

Insider Monkey

a month ago

AbCellera Biologics Inc. (ABCL): A Bull Case Theory

AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline
ABCL

Simply Wall St.

2 months ago

AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline

New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)’s Push Into Immunology and Beyond
ABCL

Insider Monkey

2 months ago

New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)’s Push Into Immunology and Beyond

AbCellera Biologics Inc. (ABCL) Appoints Chief Medical Officer
ABCL

Insider Monkey

2 months ago

AbCellera Biologics Inc. (ABCL) Appoints Chief Medical Officer

We're Interested To See How AbCellera Biologics (NASDAQ:ABCL) Uses Its Cash Hoard To Grow
ABCL

Simply Wall St.

5 months ago

We're Interested To See How AbCellera Biologics (NASDAQ:ABCL) Uses Its Cash Hoard To Grow

AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology
ABCL

Insider Monkey

5 months ago

AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology

AbCellera Biologics Inc. (ABCL): A Bull Case Theory
ABCL

Insider Monkey

6 months ago

AbCellera Biologics Inc. (ABCL): A Bull Case Theory

ABCELLERA BIOLG (ABCL) Upgraded to Buy: Here's Why
ABCL

Zacks

6 months ago

ABCELLERA BIOLG (ABCL) Upgraded to Buy: Here's Why

AbCellera Biologics And 2 Other Promising Penny Stocks To Watch
ABCL

Simply Wall St.

6 months ago

AbCellera Biologics And 2 Other Promising Penny Stocks To Watch

Why AbCellera Biologics Stock Raced Nearly 6% Higher Today
ABCL

Motley Fool

6 months ago

Why AbCellera Biologics Stock Raced Nearly 6% Higher Today

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs
ABCL

GOBankingRates

6 months ago

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

3 International Vacations That Are Cheaper Than an iPhone
ABCL

GOBankingRates

6 months ago

3 International Vacations That Are Cheaper Than an iPhone

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck
ABCL

GOBankingRates

6 months ago

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

This week in Trumponomics: Too bad TACO isn’t true
ABCL

Yahoo Finance

6 months ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right
ABCL

The Guardian

6 months ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF
ABCL

Yahoo Finance Video

6 months ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?
ABCL

Benzinga

6 months ago

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Ford recalls more than 29,000 vehicles in the US, NHTSA says
ABCL

Reuters

6 months ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

ABCL

MT Newswires

6 months ago

AbCellera Biologics Gets Health Canada Authorization for Phase 1 Trial of Dermatitis Treatment

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575
ABCL

Business Wire

6 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential
ABCL

Insider Monkey

6 months ago

AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential

Analyst Forecasts Just Became More Bearish On AbCellera Biologics Inc. (NASDAQ:ABCL)
ABCL

Simply Wall St.

6 months ago

Analyst Forecasts Just Became More Bearish On AbCellera Biologics Inc. (NASDAQ:ABCL)

ABCL

MT Newswires

6 months ago

AbCellera Biologics Gets Health Canada Approval for Phase 1 Trial of Menopause Treatment

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
ABCL

Business Wire

6 months ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

ABCL

MT Newswires

7 months ago

AbCellera Biologics Says Federal Circuit Upholds PTAB's Validity Judgment on Microfluidic Cell Culture Patent

AbCellera’s Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit
ABCL

Business Wire

7 months ago

AbCellera’s Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

AbCellera Biologics First Quarter 2025 Earnings: Revenues Disappoint
ABCL

Simply Wall St.

7 months ago

AbCellera Biologics First Quarter 2025 Earnings: Revenues Disappoint

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting
ABCL

Business Wire

7 months ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

ABCL

Thomson Reuters StreetEvents

7 months ago

Q1 2025 Abcellera Biologics Inc Earnings Call

AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
ABCL

GuruFocus.com

7 months ago

AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
ABCL

Zacks

7 months ago

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates

AbCellera Reports Q1 2025 Business Results
ABCL

Business Wire

7 months ago

AbCellera Reports Q1 2025 Business Results

AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Report Preview: What To Look For
ABCL

GuruFocus.com

7 months ago

AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Report Preview: What To Look For

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025
ABCL

Business Wire

7 months ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

3 Promising Penny Stocks With Market Caps Up To $800M
ABCL

Simply Wall St.

7 months ago

3 Promising Penny Stocks With Market Caps Up To $800M

Is AbCellera Biologics Inc. (ABCL) the Best Canadian Penny Stock to Invest in Now?
ABCL

Insider Monkey

7 months ago

Is AbCellera Biologics Inc. (ABCL) the Best Canadian Penny Stock to Invest in Now?

AbCellera to Participate at Upcoming Investor Conferences in May and June
ABCL

Business Wire

8 months ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
ABCL

Business Wire

8 months ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
ABCL

Business Wire

8 months ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider
ABCL

Simply Wall St.

8 months ago

Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider

ABCL

Argus Research

9 months ago

Daily – Vickers Top Buyers & Sellers for 03/12/2025

AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
ABCL

Simply Wall St.

9 months ago

AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

ABCL

Thomson Reuters StreetEvents

9 months ago

Q4 2024 Abcellera Biologics Inc Earnings Call

AbCellera Biologics Inc (ABCL) Q4 2024 Earnings Call Highlights: Strategic Shifts Amid ...
ABCL

GuruFocus.com

9 months ago

AbCellera Biologics Inc (ABCL) Q4 2024 Earnings Call Highlights: Strategic Shifts Amid ...

AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript
ABCL

Motley Fool

9 months ago

AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates
ABCL

Zacks

9 months ago

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates

AbCellera Reports Full Year 2024 Business Results
ABCL

Business Wire

9 months ago

AbCellera Reports Full Year 2024 Business Results

What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earnings
ABCL

GuruFocus.com

9 months ago

What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earnings

US Penny Stocks To Watch In February 2025
ABCL

Simply Wall St.

9 months ago

US Penny Stocks To Watch In February 2025

ABCL

MT Newswires

9 months ago

AbCellera Biologics Changes COO's Title to Technology Chief

One AbCellera Biologics Insider Raised Their Stake In The Previous Year
ABCL

Simply Wall St.

9 months ago

One AbCellera Biologics Insider Raised Their Stake In The Previous Year

AbCellera to Participate at Upcoming Investor Conferences in March
ABCL

Business Wire

10 months ago

AbCellera to Participate at Upcoming Investor Conferences in March

3 Promising US Penny Stocks With Market Caps Under $900M
ABCL

Simply Wall St.

10 months ago

3 Promising US Penny Stocks With Market Caps Under $900M

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025
ABCL

Business Wire

10 months ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors who own 36% of the shares, institutions hold 29%
ABCL

Simply Wall St.

10 months ago

AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors who own 36% of the shares, institutions hold 29%

AbCellera Biologics Inc. (ABCL): A Bull Case Theory
ABCL

Insider Monkey

10 months ago

AbCellera Biologics Inc. (ABCL): A Bull Case Theory

AbbVie and Simcere Zaiming link to develop trispecific antibody
ABCL

Pharmaceutical Technology

10 months ago

AbbVie and Simcere Zaiming link to develop trispecific antibody

AbCellera expands collaboration with AbbVie
ABCL

TipRanks

10 months ago

AbCellera expands collaboration with AbbVie

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
ABCL

Business Wire

10 months ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

ABCL

MT Newswires

a year ago

KeyBanc Cuts Price Target on AbCellera Biologics to $4 From $5, Keeps Overweight Rating

Is AbCellera Biologics Inc. (ABCL) Among the Best Canadian Penny Stocks to Buy According to Analysts?
ABCL

Insider Monkey

a year ago

Is AbCellera Biologics Inc. (ABCL) Among the Best Canadian Penny Stocks to Buy According to Analysts?

US Penny Stocks To Watch In December 2024
ABCL

Simply Wall St.

a year ago

US Penny Stocks To Watch In December 2024

Is AbCellera Biologics (NASDAQ:ABCL) In A Good Position To Invest In Growth?
ABCL

Simply Wall St.

a year ago

Is AbCellera Biologics (NASDAQ:ABCL) In A Good Position To Invest In Growth?

US Penny Stocks To Consider In November 2024
ABCL

Simply Wall St.

a year ago

US Penny Stocks To Consider In November 2024

AbCellera to Present at Upcoming Investor Conferences in December and January
ABCL

Business Wire

a year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
ABCL

Business Wire

a year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates
ABCL

Simply Wall St.

a year ago

AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates

AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations
ABCL

Simply Wall St.

a year ago

AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations

ABCL

Thomson Reuters StreetEvents

a year ago

Q3 2024 Abcellera Biologics Inc Earnings Call

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
ABCL

GuruFocus.com

a year ago

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...

AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
ABCL

Motley Fool

a year ago

AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates
ABCL

Zacks

a year ago

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates

AbCellera Reports Q3 2024 Business Results
ABCL

Business Wire

a year ago

AbCellera Reports Q3 2024 Business Results

AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To Know Ahead Of Earnings
ABCL

GuruFocus.com

a year ago

AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To Know Ahead Of Earnings

AbCellera to Present at Upcoming Investor Conferences in November 2024
ABCL

Business Wire

a year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap
ABCL

Simply Wall St.

a year ago

3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap

Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts?
ABCL

Insider Monkey

a year ago

Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts?

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
ABCL

Business Wire

a year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
ABCL

Business Wire

a year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?
ABCL

Insider Monkey

a year ago

AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?

Carl Hansen Buys Handful Of Shares In AbCellera Biologics
ABCL

Simply Wall St.

a year ago

Carl Hansen Buys Handful Of Shares In AbCellera Biologics

ABCL

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 08/30/2024

AbCellera to Present at Upcoming Investor Conferences in September
ABCL

Business Wire

a year ago

AbCellera to Present at Upcoming Investor Conferences in September

AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny Stocks in 2024
ABCL

Insider Monkey

a year ago

AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny Stocks in 2024

ABCL

MT Newswires

a year ago

Benchmark Downgrades AbCellera Biologics to Hold From Buy

Need To Know: The Consensus Just Cut Its AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates For 2024
ABCL

Simply Wall St.

a year ago

Need To Know: The Consensus Just Cut Its AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates For 2024

Earnings Update: AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Are Trimming Their Forecasts
ABCL

Simply Wall St.

a year ago

Earnings Update: AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Are Trimming Their Forecasts

AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures
ABCL

Simply Wall St.

a year ago

AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures

AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript
ABCL

Motley Fool

a year ago

AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript

AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates
ABCL

Zacks

a year ago

AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates

AbCellera Reports Q2 2024 Business Results
ABCL

Business Wire

a year ago

AbCellera Reports Q2 2024 Business Results

AbCellera and Lilly broadens antibody discovery partnership
ABCL

Pharmaceutical Technology

a year ago

AbCellera and Lilly broadens antibody discovery partnership

ABCL

MT Newswires

a year ago

AbCellera Biologics, Eli Lilly Expand Collaboration to Discover Antibody Therapies

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
ABCL

Business Wire

a year ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
ABCL

Motley Fool

a year ago

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

ABCL

MT Newswires

a year ago

--KeyBanc Adjusts Price Target on AbCellera Biologics to $5 From $7, Maintains Overweight Rating

AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know
ABCL

Zacks

a year ago

AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
ABCL

Business Wire

a year ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

Down 57%, Is AbCellera Biologics a Buy on the Dip?
ABCL

Motley Fool

a year ago

Down 57%, Is AbCellera Biologics a Buy on the Dip?

Share on Social Networks: